Pfizer
Tim Hogan has a diverse work experience that includes senior leadership roles in various organizations. Tim is currently serving as the Senior Vice President of Global Policy & Public Affairs at Pfizer, a position they started in April 2022. Prior to joining Pfizer, Tim worked at J.P. Morgan as a Managing Director from August 2013 to April 2022. Tim also served as Of Counsel at DLA Piper from November 2009 to August 2013. Before that, Tim held the position of Senior Fellow at the Center for American Progress from September 2007 to August 2013. Tim also worked as an Associate at Alston & Bird from September 2007 to October 2009. Tim's early career includes serving as a Legislative Aide for International & Economic Affairs in the United States Senate from July 1999 to February 2004.
Tim Hogan has attended Columbia College, Columbia University, Temple University - James E. Beasley School of Law, and Beijing Language and Culture University. No specific degree or field of study information is provided.
Pfizer
606 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.